Viewing Study NCT04093505


Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2026-01-03 @ 11:07 PM
Study NCT ID: NCT04093505
Status: TERMINATED
Last Update Posted: 2022-07-01
First Post: 2018-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
Sponsor: University Hospital Heidelberg
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module